Onco-miR-21 Promotes Stat3-Dependent Gastric Cancer Progression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA-21 (miR-21) is overexpressed in gastric cancer, but its regulatory pathways and role in tumor progression are not fully understood.
• Stat3 signaling is implicated in inflammation-associated gastric tumorigenesis.

Purpose of the Study:

• To investigate the role of miR-21 in Stat3-driven gastric cancer.
• To evaluate miR-21 inhibition as a therapeutic strategy for gastric cancer.

Main Methods:

• Utilized a mouse model of spontaneous, Stat3-dependent gastric tumors (Gp130 mice).
• Identified Stat3 binding motifs in the miR-21 gene promoter.
• Administered a miR-21-specific antisense oligonucleotide antagomir systemically.
• Assessed PTEN restoration, epithelial-to-mesenchymal transition (EMT), and extracellular matrix (ECM) remodeling in vitro and in vivo.
• Correlated STAT3 and miR-21 expression with patient survival data.

Main Results:

• miR-21 was confirmed as a Stat3-controlled driver of gastric tumor growth and progression.
• Systemic miR-21 inhibition significantly reduced established gastric tumor burden in Gp130 mice.
• miR-21 inhibition led to PTEN functional restoration, attenuated EMT, and reduced ECM remodeling.
• High STAT3 and miR-21 expression correlated with reduced survival probability in gastric cancer patients.

Conclusions:

• miR-21 mediates inflammation-associated gastric cancer progression through Stat3 signaling.
• miR-21 is a promising therapeutic target for gastric cancer and other solid malignancies with high Stat3 activity.